# 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

> **NCT01712295** · PHASE4 · UNKNOWN · sponsor: **Grossman, Michael, D.P.M.** · enrollment: 100 (estimated)

## Conditions studied

- Warts

## Interventions

- **DRUG:** 17% Salicylate with ethyl pyruvate
- **DRUG:** Salicylates

## Key facts

- **NCT ID:** NCT01712295
- **Lead sponsor:** Grossman, Michael, D.P.M.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01712295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01712295, "17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01712295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*